Substance P, a neuropeptide involved in pain signaling, reaches its highest levels in gums with active periodontal disease and bone loss, potentially linking oral inflammation to chronic pain conditions like arthritis.
Highest in active disease sitesSubstance P levels peak in gingival fluid from sites with active periodontal disease and bone loss, potentially driving neurogenic inflammation that connects to systemic pain conditions
What the researchers found
The review consolidates evidence showing that Substance P is expressed during the inflammatory process of periodontal disease and contributes to alveolar bone resorption. Studies demonstrate that Substance P levels are highest in the gingival crevicular fluid from sites with active periodontal disease and bone loss.
The persistent presence of Substance P in periodontal tissues could stimulate neurogenic inflammation in susceptible tissues and cause pain. The review identifies Substance P expressed during periodontal disease as a potential risk factor for patients with systemic inflammatory pathologies, particularly chronic arthritis and rheumatoid arthritis, suggesting a neuropeptide-mediated link between oral and systemic inflammation.
Why it matters
The connection between gum disease and systemic health has become a major focus of medical research. This review identifies Substance P as a specific molecular link between oral inflammation and chronic pain conditions. If periodontal Substance P release contributes to systemic inflammation and pain, treating gum disease could potentially reduce chronic pain symptoms in conditions like arthritis — a possibility with significant clinical implications.
How the study worked
Literature review examining published studies on Substance P levels in periodontal disease, its role in pain signaling and bone resorption, and the connection between periodontal inflammation and systemic chronic pain conditions.
What this study cannot tell us
This is a narrative literature review from 2014 that synthesizes existing studies without systematic methodology. The strength of the evidence linking periodontal Substance P to systemic chronic pain varies across the cited studies. Causation has not been established — elevated Substance P in periodontal disease could be a consequence rather than a cause of broader inflammatory processes. The review does not quantify the magnitude of Substance P elevations or the strength of the periodontal-pain association.
How to read the evidence
This is a narrative literature review from a dental journal that synthesizes observational and clinical findings. While it provides a plausible biological mechanism linking periodontal Substance P to chronic pain, the evidence is associative rather than causal, and the review does not follow systematic review methodology.
When this study was published
Published in 2014, this review captures the understanding of oral-systemic connections through neuropeptide biology from over a decade ago. The field has advanced, particularly in understanding how periodontal disease contributes to systemic inflammation, but the Substance P connection described here remains relevant and underexplored.
The bigger picture
The oral-systemic health connection is increasingly recognized, with periodontal disease linked to cardiovascular disease, diabetes, and adverse pregnancy outcomes. This review adds chronic pain to that list through the lens of Substance P — a neuropeptide that physically connects nerve fibers, immune cells, and bone-resorbing cells. Understanding how neuropeptides mediate the mouth-body connection could reshape how dentistry and medicine collaborate on patient care.
Questions still open
- Does successful treatment of periodontal disease reduce Substance P levels and improve chronic pain symptoms in patients with arthritis?
- Could Substance P receptor antagonists (like aprepitant) have dual benefits in managing periodontal inflammation and associated chronic pain?
- What is the relative contribution of periodontal Substance P to systemic inflammation compared to other oral inflammatory mediators?
Common questions
What is Substance P and why is it in gum disease?
Could treating gum disease help with chronic pain?
Read the original research
Relationship between levels of neuropeptide Substance P in periodontal disease and chronic pain: a literature review.
Journal of investigative and clinical dentistry, 5(2), 91-7
Citation
de Avila, Erica Dorigatti; de Molon, Rafael Scaf; de Godoi Gonçalves, Daniela Aparecida; Camparis, Cinara Maria. (2014). Relationship between levels of neuropeptide Substance P in periodontal disease and chronic pain: a literature review.. Journal of investigative and clinical dentistry, 5(2), 91-7. https://doi.org/10.1111/jicd.12087